Regor Therapeutics Group
Pharmaceutical Manufacturing
We aspire to be a world class innovative drug discovery company from China.
About us
Regor Therapeutics is a clinical stage company dedicated to the discovery and development of innovative and clinically differentiated medicines by leveraging the proprietary CARD (Computer Accelerated Rational Discovery) Platform. The company focuses mainly on three therapeutic areas, oncology, immunology, and metabolic disorders. By seamlessly integrating CARD with structural biology, computational chemistry, therapeutic biology, medicinal chemistry, and clinical development, Regor has successfully assembled a world-class scientific team and established a highly efficient new drug innovation engine to enable the discovery and development of best- and first-in-class molecules.
- Website
-
http://www.regor.com
External link for Regor Therapeutics Group
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Shanghai
- Type
- Partnership
- Founded
- 2018
Locations
-
Primary
Get directions
Building #10, 1206 Zhangjiang Road, Pudong
Shanghai, 201203, CN
-
Get directions
50 Soldiers Field Pl
Boston, Massachusetts 02135, US
Employees at Regor Therapeutics Group
-
Julie Xie
Head of Oncology and Immunology at Regor Therapeutics Group I Oncology Drug Discovery and Development I Project Team Leader
-
Dawn Begley
Associate Clinical Director at Regor Therapeutics Group
-
Jing Lin
VP of Preclinical Research, Regor Therapeutics Inc., a biotech focusing on the innovative drug R&D in multiple therapeutic areas
-
Tianran Liu
Partner at Vertex Ventures